Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 4Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2INDIV 2

Study Type

Observational 2Interventional 2

Sponsor

Conditions

Myasthenia Gravis 4

Interventions

Pyridostigmine Bromide 4Tacrolimus 2Prednisone 2Mycophenolic Acid 2tocilizumab 1sargramostim 1Thymectomy 1Tablets 1Steroids 1Sternotomy 1Rituximab 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Granulocyte-Macrophage Colony-Stimulating Factor 1Exercise 1Data Collection 1Cyclosporine 1Cyclophosphamide 1Azathioprine 1Amifampridine 1Alkalies 1Albuterol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Myasthenia Gravis × Pyridostigmine Bromide × Clear all
NCT05919407 2023-06-26

IMPACT-MG

Leiden University Medical Center

Phase 3 Unknown
24 enrolled

Myasthenia Gravis

NCT04101578 2021-08-23

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Da, Yuwei, M.D.

Unknown
2,000 enrolled

Myasthenia Gravis

NCT04768465 2021-02-24

Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

Da, Yuwei, M.D.

Unknown
160 enrolled

Myasthenia Gravis

NCT03510546 2018-04-27

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis

University of Aarhus

Phase 4 Unknown
44 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡